Peer Review History
| Original SubmissionMarch 6, 2022 |
|---|
|
PONE-D-22-06745Public knowledge, practices, and awareness of antimicrobials and antimicrobial resistance in Myanmar: The first nationwide mobile phone panel surveyPLOS ONE Dear Dr. Miyano, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. This investigation has some value and the findings are worthy of broader dissemination. However, reviewers identified several key methodological problems and inconsistencies throughout the paper, recommending that it be thoroughly edited and updated for improved clarity and consistency. The methodology section, in particular, needs to be fleshed out further than it is now. Please submit your revised manuscript by Jun 09 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Myo Minn Oo, M.D., Ph.D. Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly Reviewer #4: Yes Reviewer #5: Partly Reviewer #6: Yes Reviewer #7: Yes Reviewer #8: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No Reviewer #4: Yes Reviewer #5: No Reviewer #6: No Reviewer #7: Yes Reviewer #8: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: No Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: No Reviewer #7: Yes Reviewer #8: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes Reviewer #7: Yes Reviewer #8: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Abstract: - Better to mention the survey period Introduction: - Better to show some highlights from AMR awareness surveys (India, Indonesia, and Thailand) of WHO South-East-Asian region - It will be better if the author can brief a paragraph about the highlights on magnitude and prevalence of AMR in Myanmar if the data is available Materials and Methods: - It is needed to describe a brief on the sampling methodology (how to get the sampling frame and how the sample from the sampling frame were selected) General Comments on Tables - Tables and figures should be standalone and contains as much information related to the data as possible and abbreviations used in the tables should be described in long form in foot notes. - It is better to highlight/bold/annotate the significant p-values for better visualization Table 2: - Title: to include the where and when of the survey - To add footnote and should mention what is the % means (e.g., row percentage or column percentage) Table 3: - Same comment as table 2 Table 4: - Same comment as table 2 Table 5: - Same comment as table 2 Table 6: - Same comment as table 2 Discussion: - It is better to add a paragraph on strength of this study Reviewer #2: 1. In the data collection method, please mention how many trained interviewers were used in this study and add the average duration of the phone interviews. 2. In Table (1), A3 question stated that “If yes in A2, where did you acquire the last course of antibiotic?”, but the above A2 question was not “yes/no” question. Therefore, please make sure A2 question is correct. Reviewer #3: I am thankful to the editors and authors for giving me a chance to review this manuscript. It's overall well written by the results from a mobile phone panel survey among relatively large samples of the Myanmar population. For me, however, major improvements should be made on materials and methods and result sections to publish it in PlosOne. Abstract - Page 2, Line 33, the word “younger individuals” is misleading. Consider rephrasing or including the age range in years. - Page 3, Line 39, a concluded sentence is unclear for me. What does it mean to “effective interventions”? Introduction - Introduction is relatively short and lacks detailed information concerning the AMR situation in Myanmar, the current healthcare system including challenges towards universal health coverage, and weaknesses in drug regulations, etc. - It’d be better to include why authors chose the mobile phone panel for data collection and its efficiency referencing other literature or studies. Materials and Methods - Authors used MPPS as a data collection tool in this study. However, I believe authors should describe it in detail so that readers can understand easily about it. - By a mobile phone panel, how did you ensure the involvement of similar gender, age, and residential area? - Please include operational definitions of the variables (e.g., what does it mean “Urbanity”?) - For data collection, given that mobile phone connections are a bit terrible in Myanmar, there might be some dropped out calls. How did you handle it? - There might also be some people holding multiple numbers. - We should have included routine QA and QC for collected data, if any. - How did you validate the age of respondents by a call. Other family members could pick up phone calls rather than the owner of your intended number. Amid an increase in the number of dialers by some companies to promote their products or services, people nowadays avoid picking up such calls. - How did you verify the translation of the questionnaire is correct and concise (e.g., back-translation method)? - Authors mentioned making modifications to some questions after the pretest. What were those? Did you run any statistics to test its validity and reliability? Please consider attaching the Questionnaire in Burmese as a support file. - Questionnaire was composed of four sections. How about general characteristics such as age, gender, and residential areas of respondents? - Describes full name when it appeared first (e.g., SPSS) - Line 117 – Authors mentioned about 95% CIs, but I did not find it in the later part. - Please refer to the correct name of the IRB board from Myanmar @ https://irbdmr.gov.mm/. Results - Analysis is a kind of thin. I have observed that there were inequalities in the residential areas of the respondents. How did the authors make an account of such bias? - In Table 1, there were some open-end questions (e.g., Q-C4). However, I did not find detailed results under the result section. - Please include footnotes under each table as relevant (e.g., degree of freedom for Chi-square test, differentiations whether Fisher Exact or Chi-square is used for each variable) - Age range (mean, min and max) for the respondents should be included. Some older people might have a problem in answering the phone or they are dependent on other family members who are usually taking care for their medications. Discussion - This part looks vast by including many things from the result section. I would suggest revising it in concise form, consider adding more about authors insights reflecting current situation in Myanmar. - One other limitations of this study would be lacking information from provider side (e.g., Knowledge of pharmacist/ pharmacy). Normal person might be remote from A/ AMR awareness, at least, most respondents went to clinics, medical stores, or pharmacies for buying medicines rather than seeking self-treatment. - Line 306-307, consider rephrasing the sentence to reflect current COVID-19 preventive measures in Myanmar. Other minor comments - Please recheck the format of the references, e.g., 1, 3, 7, 12, 14, 15. - Ensure language errors, e.g., line 85 “High-frequency panel data nationwide.” Reviewer #4: Reviewer’s comment Overall comment: The manuscript tackles an important research area, antimicrobial resistance, which is a global health concern. The findings of the study were applicable as it identified the gaps in the knowledge, practices and awareness on antimicrobial resistance among Myanma population. The survey method was Mobile Phone Panel Survey approach which was reported as a successful cost-effective tool during these years. However, there are some major concerns regarding research tool and some facts that the authors may need to clarify for the improvement of the manuscript. Major Comments - Regarding the title, the authors may need to take a care while using the word “nationwide” . That issue is needed to be clarify in this revision. So after clarifying this, the title should be considered again. - - Regarding the methodology section, it is need to clarify the followings; - how to achieve the national representative sample for Myanmar? Which sampling method was used to achieve representative MPPS for nationwide distribution? - The author described the sample size but may need to mention the sampling frame clearly. - How the authors perform representative MPPS?, face-to-face baseline interview approach was not conducted? Which approach was used to get the phone numbers of potential respondents/participants? random digit dialing (RDD) ? How to get a database of telephone numbers to draw a representative sample? - how did you select the participants from each regions and states in Myanmar to get representative samples for urban/rural population within the each state and region? - The authors described that out of 14 states and regions, participants from 12 states and regions were included; the author may need to mention which state/region were not included in the study and what is the reason (I found low population area in the discussion section) but need to clarify clearly? and need to mention how many representative participants were included in each state and region as the distribution of population is different among states and region in Myanmar. Were urban and rural population samples distributed equally within the each state/region or within the whole country? - The authors mentioned in the Data Analysis session about the weighing factor was calculated based on National Census Data for gender/age/urbanity, please describe details how to stratify these three groups and how to ensure the validity of these info of the participants? - The classification for “rural and urban area” is needed to be mention, which references ? census data? Moreover, a working definition for “residence of rural and urban area “ should be included eg. The respondence must be at least --- years of residing in rural/urban area etc.., Did the authors exclude those who just move in in urban area? - Regarding the Reference section, many references were found to be following the Journal’s referencing style, the authors should take a thorough care to follow strictly to the author’s guidelines of the Journal Minor comments Line 20- pls correct as “Myanmar National Action Plan for Containment of Antimicrobial Resistance (2017-2022)” Line 21- Pls write as “Ministry of Health and Sports, Myanmar” Line 24- -Pls add the time of the study; eg.“….conducted MPPS during 2020.. ” Line 33- Pls mention the age group instead of “younger” Line 112- Pls mention “SPSS” in full “Statistical Package…..” Line 136- table 2 should be after the paragraph for “Recognition of antibiotic”, is the recognition used there is the correct term? Pls delete “full stops” in the titles of table 2,3,4 and 5 Line 230-232 is repeating the Line 227-229 Line 322 -333- It is more suitable in introduction section as it explained about MPPS and Myanmar situation. In the discussion the author should mention limitation (as in Line 320-322) and advantages (as in Line 333-338) of the present study precisely. Line 374- Strep pneumoniae- italic Ref 7 and 14 are overlapping, and the ref style for WHO, European Union (Ref 15) were not correct and other references are needed to be checked with Journal’s referencing style Reviewer #5: This study is important for baseline data for the antimicrobial use and antimicrobial resistance in Myanmar. As this study is the first nationwide data, there are some considerations especially methodology I want to point out. Title: Public knowledge, practices, and awareness of antimicrobials and antimicrobial resistance in Myanmar: The first nationwide mobile phone panel survey But the authors stated their aim of the study as "this study aimed to assess public knowledge and practices concerning antibiotics, as well as awareness of antibiotic resistance, to provide baseline evidence and identify gaps related to the deployment of strategic awareness-raising activities in Myanmar". Moreover, the questionnaires are asked about antibiotics only. For non -expert readers, I think some clarifications are needed in the terms of antimicrobial or antibiotics (or) changing the title by using antibiotics only Introduction The authors should include other previous evidences from Myanmar even though they are not nationwide. From that, international audience can estimate the prevalence and burden of the interesting issue in Myanmar and the authors can explain the results in discussion. Method Before going to details, the authors should follow STROBE (for cross sectional study) reporting guideline especially for the method section because this is the most important part to decide the validity and reliability of the study. Sample size: line 85 to 94: The authors stated the steps to get the required sample size 1940. But there is difference what the reference book stated. According to the reference, Mobile phone panel survey in developing countries by world bank, in page 24, sample size calculation https://openknowledge.worldbank.org/bitstream/handle/10986/24595/9781464809040.pdf?sequence=2&isAllowed=y, the required sample size will be 3876 for 6 layers of stratifications (urban/rural, male/female, Younger/older). That is only for 2 layers of age stratification. If you have more layers, it will be increased according to the layers. Please refer to the above link and justify the required sample (or) only mention another appropriate sample size calculation techniques. Questionnaires: Line 101 to 104: The authors stated the pretest was done. If any item analysis was done, please stated the results which will increase the validity of the questionnaires. Moreover, the study was claimed as nationwide study and to get baseline information, the authors should express detail procedure of development of the questionnaires and testing the internal and external consistency. I Usually, the questionnaires contain general information of the study population as part A. I believe the authors already had that part. If so, please mention it and the data must show in the result section also. Because the readers want to know the general information of the study population. According to the question A1, the population will divide 2, Yes and no. Further questions are based on "Yes" sub population. It is not clear whether the authors apply questions B, C and D to all participants or only to those who answer to Yes in question A1. Please mention it clearly in the method section and data analysis section for any sub group analysis. Data Analysis: Thank to the authors for considering the sampling weights to reduce the bias. But need to mention any sub group analysis and how to handle the nonresponse rate because non response rate is important for MPPS. Since the authors expressed the difference between groups, I suggest to calculate multivariable analysis for confounder-adjusted estimates to minimize the bias and show the strength of association. Result Again, I recommend to stick the reporting guideline. Please give the characteristics of study participants like Age, gender, residence, education, occupation, socioeconomic status etc Please indicate number of participants with missing data or non-response rate. Since this is a survey type study, the readers want to know the non-response rate. I know the table 3,4 and 5 are representing the sub groups. I am not sure the table 6. Please specify the total number of each group in the heading of the tables and in the test also. It is confused the readers. It is better if the authors show the flow diagram of the number of the response of the participants. Discussion The whole discussion is well written and can explain the result well. Recommendation is also appropriate. But it can change after the authors adjust the data analysis. As I mention before, more Myanmar contexts/studies should be discussed here. Strength and limitation of the study Line 325-338, the authors want to express why they use MPPS. So, the whole para graph should express in the introduction or beginning of the method. The authors should address other important factors such as social and economic factors which influence the results. Any potential bias should be expressed here. Reviewer #6: The study covers important public health topic and it is very timely. The manuscript reads very well. Some comments for the better understanding on the method applied and findings. Method Line number - 84-85/ 98 - Please consider giving some clarification on the phrase "representative, high-frequency panel data". And some detail on how the sample frame was identified? How the samples were randomly selected? Was response rate taken into account when sample size was calculated? Line number - 91 - there was a plan to do series of survey and sample size was calculated to compensate 5% attrition rate. It is suggested to elaborate more about the plan in discussion or where relevant. Line 102 - Any references used in the development of the questionnaire? Did the authors use standard questionnaire and any reference on its reliability? Line 111 - Data were double-entered into Excel. Please include the reason of doing double entries and was there any inconsistency when/if the authors did data validation? If so, how were the errors managed? Line 117 - Method used for calculating 95% CI was presented but no 95% CI was reported in the result session. It is suggested to include 95% CI. Important socio-economic factors such as education, income, occupation should be considered including in future surveys. Results What is the response rate? Line 133-134 - 68.5% lived in urban area. It is different from the data presented in table 2 where 68.5% lived in rural. When giving the p-values for difference groups comparison in result narrative, it is better to move the p value to the place near to variable name rather them writing all p values in the parenthesis at the end of the statement which sometimes is difficult to interpret. Conclusion Line 349-351 - Prediction on the use of antibiotics during the COVID19 pandemic is not based on the current study findings and better to rephrase as a recommendation and/ or move it to discussion by giving the appropriate references. Reviewer #7: Congratulations for your well prepared manuscript. May I suggest to add some modifications by the following comments: Line 22-23: Paraphrase of the aim will be better if it is consistent with the title of manuscript. Line 93: Reference for sample size consideration and formula for attrition rate should be cited. Line 99: How are the panels framed for random selection of each participant? Line 316: Awareness raising on antibiotic use, antibiotic resistance and banning of antibiotic use in farm animals should be highlighted for rural people because they occupied for about two third of Myanmar population and are exposed more to farm animals than urban residents. Line 306-307, 332-333: Along with increasing ownership of mobile phones in Myanmar, mobile health education by mean of text messages about antimicrobials use and antimicrobial resistance should be recommended as communication channel of awareness raising campaign. Reviewer #8: Summary of the research and overall impression This manuscript presented to access the knowledge, awareness and practice of using antibiotics among general populations in Myanmar using MPPS. Methodology session is required to revise/ add more detail information in terms of sampling, study period, data collection approach and data management. Data analysis is stated clearly. The results session is clear but the discussion and conclusions are required to improved. This study will benefit to the community and national AMR program to strategically implement the national AMR action plan. I would agree to publish this article for wider data dissemination purpose to the academic audience as well as useful for the uptake by the national program. It is recommended to improve the English language for academic writing and publication. For example, the use of tense (verb) in the results and discussion sessions should be past tense. The terms should be consistent: “participants” or “respondents” or “citizens” throughout the paper. Similarly, the term “overuse” or “misuse” should be consistent. If “overuse” and “misuse” are different definition, please elaborate in methods session. Discussion on specific area of improvement Abstract1. The information presented in the abstract is clear, concise and complete. Thank you. Please add how the participants were randomly selected from which sampling frame. It said “from the panel” – please elaborate more what is the “panel” represent for. Introduction 2. Add the key findings from the 3 countries in SEA region (India, Indonesia and Thailand) – eg. the proportion of public awareness and understanding about AMR in these counties. 3. List the countries where the WHO AMR nationwide survey was conducted in the SEA region. 4. Mention additional information about the national AMR program in Myanmar and the action/ activities implementing for AMR strategic action plan. Methods5. Explain the sampling procedure – how the participants were chosen from the panel data nationwide. 6. Table 1 – please move it to Annex. 7. Clarify the “period of the study” and “study areas” included in the study where the participants were enrolled in the survey.8. Suggest to mention about “data management”, such as data cleaning and checking, how the data was stored for such a certain period of time, data security measure, etc.9. Add the information about non-response rate, which is important for mobile phone interviews using IVR at the call center. 10. Mention how the data quality check was conducted (in a real-time?) for IVR and mobile phone interviews. Any follow up questions if the data is incomplete or occurs with errors. Ethical considerations 11. Line 126 – please double check the name of the institutional board for ethical review. I assume it should be “Institutional Review Board”, not “Institutional Research Board”. Results 12. Move the study period to the methods session. 13. The sample size (in the methods session) said 1940 participants, but how it was ended up with 2045 participants. Please explain in the methods session and in results session, total sample size is enough to present. 14. Line 133 – 68% lived in RURAL areas (according to the data from the table). Please correct. 15. Mention the proportion of participants in each state/ region in the Annex table. Discussion and conclusions16. Line 226 – “excellent representation” is not the academic writing; reflecting cannot measure how much “excellent” stands for. Please mention scientifically for the representativeness of the sample populations from the study. 17. In general, add the data from other literatures/ studies when explaining about the comparisons of data from this study findings, rather than mentioning “less likely” or “more likely”, so that the readers can get more detail understanding of how the differences is small or large in this study, compared to other studies. 18. Line 242-245 (…nationwide dissemination……multiple communication channels.) – how did you get this recommendation to be accomplished the knowledge dissemination in Myanmar. Please refer to and double check with the findings that can reference for this recommendation. 19. Line 266-267 (…in reality……without prescription.) – this statement is not included in the findings. Please add the reference if relevant or please remove the statement if that is not from the findings or no reference can be added. You may not want to add information without any evidence or reference in the discussion. 20. Line 309 – you cannot state “people from Myanmar” because this study was conducted in a sample population of Myanmar. You can state that “in this study, participants were less likely….”21. Line 317-319 – suggest to mention that further collaboration with the agriculture, livestock and veterinary department for providing proper training and education program to the farmers and livestock, breeding farms regarding the AMR. 22. Limitation: mention the weakness of mobile phone survey, instead to face-to-face survey (eg. non-response rate). 23. Please mention anything about the safeguarding measures applied throughout the MPPS survey approach. If not, add this as the limitation. 24. However, the later part of the paragraph (line 327 onwards) stated about the advantage of MPPS. In this case, please present clearly “limitation” and “strength” of the survey. In addition, please also add the literature and reference about using MPPS methodology. Reference from Oxfam related to CATI (using phone interview) is provided for additional reference as necessary. Conclusion 25. COVID-19 related AMR situation is just appeared in the conclusion. It is agreeable to include and discuss about this survey conducted before COVID-19 pandemic. Thus, include or move some information about COVID-19 related AMR situation in the discussion first, then present it again to conclude how this data could be impacted after the COVID-19 pandemic. 26. The facts in conclusion should be more concisely presented one by one, rather than general presentation. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No Reviewer #4: No Reviewer #5: No Reviewer #6: No Reviewer #7: No Reviewer #8: Yes: POE POE AUNG [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Public knowledge, practices, and awareness of antibiotics and antibiotic resistance in Myanmar: The first national mobile phone panel survey PONE-D-22-06745R1 Dear Dr. Miyano, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Monica Cartelle Gestal, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #4: All comments have been addressed Reviewer #5: All comments have been addressed Reviewer #7: All comments have been addressed Reviewer #8: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #4: Yes Reviewer #5: Partly Reviewer #7: Yes Reviewer #8: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #4: Yes Reviewer #5: N/A Reviewer #7: Yes Reviewer #8: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #4: Yes Reviewer #5: No Reviewer #7: Yes Reviewer #8: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #4: Yes Reviewer #5: Yes Reviewer #7: Yes Reviewer #8: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: As the author have corrected according to the comments, my recommendation for this paper is "Accept". Reviewer #4: Reviewer’s comment for R1` Overall comment: The authors thoroughly revised the R1 and answers almost satisfactorily to the reviewer’s comments and suggestions. On my point of view, only the minor correction is needed for further revision. Major Comments Title and Methodology: - the authors explained well how to achieve representative samples for nationwide distribution in their point by point response. The authors changed the “ nationwide” to “national” in their R1 manuscript - I’d like to suggest the wording “nationwide MPPS” is more appropriate than “national” but the authors should mention the selected 12 States and Regions out of total 15 in Myanmar in the “Methodology” section. And should mention reasons of excluding Kayah, Chin and Rakhine in “Methodology” or “Limitations of the study” section. - The authors explained well about the above mentioned points in the point by point response to my comments and also mentioned the selected States and Regions in the table/info sheet. However, these facts should be clearly mentioned in the text of manuscript, so that the readers can clearly see these facts and it gives the strength for “nationwide survey” research article. - The authors explained clearly the sampling frame in the response as “ planned sample 2216 was distributed 16 demographic segments which are gender, age and urbanity. Thus 133 samples were collected from each segment …………… - These facts should be included in the methodology section to be able to make clear description to the readers. Minor comments Abstracts - Line 20-22 should be divided into two sentences instead of using long sentence. “In 2017… Ministry of Health and Sports, Myanmar. One of its objectives…” Ethical Considerations - Line 162, correct as “Institutional Review Board for Biomedical Research involving human subjects” Reviewer #5: Although the authors have responded almost all questions adequately, the nature of the study is descriptive study. I have no more comments. Reviewer #7: Thank you for your thorough reply to each of my comments. Your well updated manuscript is hope to be published soon. Reviewer #8: Thank you the first author and co-authors addressing all the comments from the many reviewers. Really appreciate to produce this paper which is important for Myanmar AMR response. I accept the revision and no further comment. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #4: No Reviewer #5: No Reviewer #7: No Reviewer #8: Yes: Poe Poe Aung ********** |
| Formally Accepted |
|
PONE-D-22-06745R1 Public knowledge, practices, and awareness of antibiotics and antibiotic resistance in Myanmar: The first national mobile phone panel survey Dear Dr. Miyano: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Monica Cartelle Gestal Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .